QuiaPEG Pharmaceuticals Holding
0,02 SEK +13,79 %Vær den første som følger denne virksomhed
QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
QUIA
Daglig lav / høj pris
0,016 / 0,024
SEK
Markedsværdi
27,27 mio. SEK
Aktieomsætning
2,75 mio. SEK
Volumen
134 mio.
Finanskalender
Generalforsamling
15.06.2023
Delårsrapport
22.08.2023